G1 Therapeutics, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
G1 Therapeutics, Inc. Amended and Restated Clawback Policy
G1 Therapeutics, Inc.
Biotechnology
2024
First Amend
G1 Therapeutics, Inc.
Biotechnology
NC
2023
Senior Advisor Agreement between Registrant and Jennifer K. Moses dated February 28, 2023
G1 Therapeutics, Inc.
Biotechnology
2023
Description of Securities of the Registrant
G1 Therapeutics, Inc.
Biotechnology
2022
Scientific, Clinical, and Regulatory Advisor Agreement by and between the Registrant and Seth A. Rudnick, MD, effective July 1, 2021
G1 Therapeutics, Inc.
Biotechnology
NC
2021
Description of Securities of the Registrant
G1 Therapeutics, Inc.
Biotechnology
2021
Senior Advisor Agreement between Registrant and Mark A. Velleca, M.D., Ph.D. dated September 29, 2020
G1 Therapeutics, Inc.
Biotechnology
2020
Senior Advisor Agreement between Registrant and John E. Bailey, Jr. dated September 29, 2020
G1 Therapeutics, Inc.
Biotechnology
2020
Co-Promotion Agreement by and between the Registrant and Boehringer Ingelheim Pharmaceuticals, Inc., dated June 29, 2020
G1 Therapeutics, Inc.
Biotechnology
DE
2020
Scientific, Clinical, and Regulatory Advisor Agreement, by and between the Registrant and Seth A. Rudnick, M.D., effective July 1, 2020
G1 Therapeutics, Inc.
Biotechnology
NC
2020
Inducement Grant Option Agreement by and between the Registrant and Soma Gupta dated March 31, 2020
G1 Therapeutics, Inc.
Biotechnology
NC
2020
Description of Securities of the Registrant
G1 Therapeutics, Inc.
Biotechnology
2020
Amended and Restated 2017 Employee, Director and Consultant Equity Plan
G1 Therapeutics, Inc.
Biotechnology
DE
2018
DIRECTOR AGREEMENT
G1 Therapeutics, Inc.
Biotechnology
NC
2017
THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
G1 Therapeutics, Inc.
Biotechnology
NC
2017